19-46746071-G-A
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_024301.5(FKRP):c.-272G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 30)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
FKRP
NM_024301.5 5_prime_UTR
NM_024301.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.763
Publications
1 publications found
Genes affected
FKRP (HGNC:17997): (fukutin related protein) This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-46746071-G-A is Pathogenic according to our data. Variant chr19-46746071-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 522865.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=1}.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FKRP | NM_024301.5 | c.-272G>A | 5_prime_UTR_variant | Exon 1 of 4 | ENST00000318584.10 | NP_077277.1 | ||
STRN4 | NM_013403.3 | c.282+78C>T | intron_variant | Intron 1 of 17 | ENST00000263280.11 | NP_037535.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 genomes
Cov.:
30
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1059496Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 515342
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1059496
Hom.:
Cov.:
26
AF XY:
AC XY:
0
AN XY:
515342
African (AFR)
AF:
AC:
0
AN:
19798
American (AMR)
AF:
AC:
0
AN:
7178
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
12408
East Asian (EAS)
AF:
AC:
0
AN:
22418
South Asian (SAS)
AF:
AC:
0
AN:
43354
European-Finnish (FIN)
AF:
AC:
0
AN:
23414
Middle Eastern (MID)
AF:
AC:
0
AN:
2952
European-Non Finnish (NFE)
AF:
AC:
0
AN:
886482
Other (OTH)
AF:
AC:
0
AN:
41492
GnomAD4 genome Cov.: 30
GnomAD4 genome
Cov.:
30
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2I Pathogenic:1
Jan 11, 2017
Undiagnosed Diseases Network, NIH
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Uncertain:1
Aug 01, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
PM2, PM3 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.